| Renal transport of uric acid: evolving concepts and uncertainties. | |
| | |
MedLine Citation:
|
PMID: 23089270 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In addition to its role as a metabolic waste product, uric acid has been proposed to be an important molecule with multiple functions in human physiologic and pathophysiologic processes and may be linked to human diseases beyond nephrolithiasis and gout. Uric acid homeostasis is determined by the balance between production, intestinal secretion, and renal excretion. The kidney is an important regulator of circulating uric acid levels by reabsorbing about 90% of filtered urate and being responsible for 60% to 70% of total body uric acid excretion. Defective renal handling of urate is a frequent pathophysiologic factor underpinning hyperuricemia and gout. Despite tremendous advances over the past decade, the molecular mechanisms of renal urate transport are still incompletely understood. Many transport proteins are candidate participants in urate handling, with URAT1 and GLUT9 being the best characterized to date. Understanding these transporters is increasingly important for the practicing clinician as new research unveils their physiologic characteristics, importance in drug action, and genetic association with uric acid levels in human populations. The future may see the introduction of new drugs that act specifically on individual renal urate transporters for the treatment of hyperuricemia and gout. |
| | |
Authors:
|
Ion Alexandru Bobulescu; Orson W Moe |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Advances in chronic kidney disease Volume: 19 ISSN: 1548-5609 ISO Abbreviation: Adv Chronic Kidney Dis Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-10-23 Completed Date: 2013-04-10 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 101209214 Medline TA: Adv Chronic Kidney Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 358-71 Citation Subset: IM |
Copyright Information:
|
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Departments of Internal Medicine and Physiology and the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-8856, USA. alexandru.bobulescu@utsouthwestern.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biological Transport Glucose Transport Proteins, Facilitative / metabolism Gout / metabolism*, physiopathology Humans Hyperuricemia / complications, metabolism* Kidney / metabolism* Kidney Tubules, Proximal / metabolism* Organic Anion Transporters / metabolism Organic Cation Transport Proteins / metabolism Uncertainty Uric Acid / metabolism* |
| Grant Support | |
ID/Acronym/Agency:
|
K01 DK090282/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Glucose Transport Proteins, Facilitative; 0/Organic Anion Transporters; 0/Organic Cation Transport Proteins; 0/SLC22A12 protein, human; 0/SLC2A9 protein, human; 69-93-2/Uric Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Reframing family-centred obesity prevention using the Family Ecological Model.
Next Document: Changes in serum urate and urate excretion with age.